Lungevity promotes change in the lives of people diagnosed with lung cancer


WASHINGTON, April 2, 2019 / PRNewswire / – LUNGevity Foundation, the nation's leading non-profit organization focused on lung cancer, today released a report showing its impact on the rapidly advancing field of research and treatment of lung cancer patients. The report demonstrates the impact of LUNGevity on improving outcomes for lung cancer patients through a better understanding of diagnosis, treatment and quality of life, as well as conducting research and policy reforms. More people are now living well with lung cancer than ever before.

The report shows advances in the Foundation's research program, patient services, major initiatives, fundraising achievements, marketing reach and more, and how these accomplishments help to drive progress in all areas of the lung cancer field . Issuing this report celebrates advances in the field of lung cancer by encouraging people to join the organization to fund shocking research, advocate for change, create tools and resources for support and education, and raise funds for progress.

"We hope that seeing the impact that patient advocacy can have on the community of lung cancer patients inspires others to see the difference they can make as well." Andrea Ferris, President and CEO of LUNGevity, said. "As the largest and most trusted lung cancer in the country, we encourage others to join us in our work. I am proud of the work that LUNGevity is doing to improve outcomes for people diagnosed with lung cancer and I applaud everyone in our staff, and all of our constituencies, who are making change happen. We have the greatest impact when we work together. "

LUNGevity is dedicated to promoting an increasingly active community of lung cancer patients – more empowered patients, more long-term survivors, and more living with lung cancer.

About LUNGevity Foundation
LUNGevity is the leading national lung cancer organization that invests in translational and life-saving research, as well as providing support and education services for patients and caregivers. The objectives of LUNGevity are threefold: (1) to accelerate research for patients, (2) to empower patients to be active participants in their treatment decisions, and (3) to remove barriers patients face in order to access the right treatments.

LUNGevity Foundation is firmly committed to making an immediate impact on improving the quality of life and survival of people with lung cancer, accelerating research on early detection and more effective treatments, as well as providing community, support and education for all affected by the disease. disease. Comprehensive features of LUNGevity include a medically controlled site with the latest information on all aspects of the disease, a free HELPLine in partnership with Cancer.Caution®, a unique Lung Cancer Navigator application, peer-to-peer guidance for patients and caregivers (LUNGevity LifeLine), and survival conferences. LUNGevity also helps patients find and navigate clinical trials through our Clinical Trial Locator tool, a Clinical Trials Ambassador program, and participation with EmergingMed.

Our vision is a world where no one dies of lung cancer. For more information on the LUNGevity Foundation, a charity Navigator four-star organization, visit

About lung cancer in the USA

  • About 1 in 16 Americans will be diagnosed with lung cancer in their lifetime
  • More than 234,000 people in the US will be diagnosed with lung cancer this year
  • About 60-65% of all new diagnoses of lung cancer are among people who have never smoked or are ex-smokers
  • Lung cancer takes more lives than the next three major cancers (colorectal, breast and prostate) combined
  • Only 19% of all people diagnosed with lung cancer will survive 5 years or more, BUT if caught before it spreads, the chance of a 5-year survival improves dramatically

SOURCE LUNGevity Foundation

Related Links


Source link